North Korea vs South Asia (IDA & IBRD): Immunization, HepB3
North Korea
99.0%
in 2024
South Asia (IDA & IBRD)
94.5%
in 2024
North Korea rank
1st
South Asia (IDA & IBRD) rank
1st
Immunization, HepB3 over time
- North Korea
- South Asia (IDA & IBRD)
How they compare
North Korea currently reports 99.0% against 94.5% in South Asia (IDA & IBRD), a difference of 4.5%.
Across all 22 years both countries report, North Korea has been ahead every year.
North Korea ranks 1st and South Asia (IDA & IBRD) ranks 1st of 188 countries.
North Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | North Korea | South Asia (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.3% | 20.5% | 63.8% | North Korea |
| 2010s | 95.2% | 77.2% | 18.0% | North Korea |
| 2020s | 98.6% | 90.6% | 8.0% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, North Korea or South Asia (IDA & IBRD)?
- North Korea, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, hepb3 between North Korea and South Asia (IDA & IBRD)?
- 4.5%, with North Korea ahead.
- How many years of comparable data are there for North Korea and South Asia (IDA & IBRD)?
- 22 years are reported by both, from 2003 to 2024.
- How do North Korea and South Asia (IDA & IBRD) rank globally for immunization, hepb3?
- North Korea ranks 1st and South Asia (IDA & IBRD) ranks 1st of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.